Table 2.
Estimated standardized mean difference between treatment groups before and after propensity score weighting
| Variables | Standardized differences | Variance ratio | ||
|---|---|---|---|---|
| Raw | Weighted | Raw | Weighted | |
| TZD vs. SU | ||||
| Age, year | − 0.1263 | − 0.0201 | 0.9809 | 1.0076 |
| Male vs. Female | 0.0043 | − 0.0027 | 1.0016 | 0.9991 |
| BMI, kg/m2 | 0.2837 | − 0.0231 | 1.3183 | 0.9799 |
| ln(FPG), mg/dL | − 0.2419 | 0.0511 | 0.8574 | 1.2458 |
| HT | 0.0012 | − 0.0129 | 0.9984 | 1.0205 |
| eGFR group < 90 ml/min/1.73 m2 | − 0.1037 | − 0.0084 | 1.0659 | 1.0057 |
| CVD | − 0.1110 | − 0.0004 | 0.6654 | 0.9989 |
| Statin | 0.1172 | − 0.0205 | 0.8915 | 1.0186 |
| HDL-C, mg/dL | 0.0847 | − 0.0100 | 1.0447 | 1.0442 |
| Triglycerides, mg/dL | − 0.0717 | 0.0803 | 1.0053 | 8.9630 |
| LDL-C, mg/dL | − 0.0729 | − 0.0042 | 0.9187 | 1.0439 |
| ACEi/ARB | 0.0373 | − 0.0142 | 1.0013 | 0.9991 |
| DPP4i vs. SU | ||||
| Age, year | 0.2436 | − 0.0111 | 1.0056 | 1.0908 |
| Male vs. Female | − 0.0374 | 0.0074 | 0.9870 | 1.0023 |
| BMI, kg/m2 | 0.0280 | 0.0019 | 1.0991 | 1.0250 |
| ln(FPG), mg/dL | − 0.1617 | 0.0065 | 0.9541 | 1.1660 |
| HT | 0.1247 | 0.0027 | 0.8056 | 0.9957 |
| eGFR group < 90 ml/min/1.73 m2 | − 0.0207 | 0.0003 | 1.0149 | 0.9998 |
| CVD | 0.2104 | − 0.0020 | 1.7271 | 0.9940 |
| Statin | 0.1275 | − 0.0080 | 0.8810 | 1.0073 |
| HDL-C, mg/dL | − 0.0031 | − 0.0053 | 1.1262 | 1.1293 |
| Triglycerides, mg/dL | − 0.0624 | 0.0109 | 0.7698 | 1.1319 |
| LDL-C, mg/dL | − 0.1704 | 0.0227 | 1.0567 | 1.2859 |
| ACEi/ARB | 0.0200 | 0.0015 | 1.0011 | 1.0001 |
| SGLT2i vs. SU | ||||
| Age, year | − 0.1716 | 0.0036 | 1.1340 | 0.9964 |
| Male vs. Female | 0.0872 | 0.0154 | 1.0233 | 1.0048 |
| BMI, kg/m2 | 0.5720 | 0.0204 | 1.6763 | 1.1053 |
| ln(FPG), mg/dL | − 0.4200 | 0.1604 | 0.6622 | 1.1047 |
| HT | 0.1278 | 0.0657 | 0.8029 | 0.8939 |
| eGFR group < 90 ml/min/1.73 m2 | − 0.3782 | − 0.0722 | 1.1352 | 1.0444 |
| CVD | 0.5425 | 0.0225 | 2.8544 | 1.0672 |
| Statin | 0.1855 | 0.1306 | 0.8224 | 0.8670 |
| HDL-C, mg/dL | − 0.1733 | 0.0041 | 0.9205 | 1.1982 |
| Triglycerides, mg/dL | − 0.0259 | − 0.1194 | 1.0624 | 0.5776 |
| LDL-C, mg/dL | − 0.2757 | − 0.0246 | 1.1049 | 1.3047 |
| ACEi/ARB | 0.0897 | 0.0026 | 1.0009 | 1.0001 |
ACEi: Angiotensin-converting enzyme inhibitors; ARB: Angiotensin receptor blockers; BMI: Body mass index; CVD: Cardiovascular disease; DPP4i: Dipeptidyl peptidase-4 inhibitors; eGFR: Estimated glomerular filtration rate; FPG: Fasting plasma glucose; HDL-C: High density lipoprotein cholesterol; HT: Hypertension; LDL-C: Low density lipoprotein cholesterol; SGLT2i: Sodium-glucose cotransporter-2 inhibitors; SU: Sulfonylureas; TZD: Thiazolidinediones